Erythropoiesis-stimulating Agent [EPC]

54073 reported adverse events

Drugs of this class: DARBEPOETIN ALFA

These side effects are most commonly reported by patients taking drugs of the Erythropoiesis-stimulating Agent [EPC] class:

# Side effect Count
0 DEATH 16296
1 HOSPITALISATION 6211
2 OFF LABEL USE 2624
3 ANAEMIA 2197
4 HAEMOGLOBIN DECREASED 1664
5 PRODUCT STORAGE ERROR 1623
6 PNEUMONIA 1504
7 FATIGUE 1491
8 DYSPNOEA 1458
9 DIARRHOEA 1339
See all common reactions for Erythropoiesis-stimulating Agent [EPC]

Drugs of the Erythropoiesis-stimulating Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 290 0.7494
1 ANTACID THERAPY 89 0.6846
2 SLEEP DISORDER THERAPY 125 0.6313
3 SHUNT STENOSIS 134 0.4838
4 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 120 0.4781
5 ANALGESIC THERAPY 138 0.4299
6 DRUG THERAPY 135 0.3982
7 ARTERIOVENOUS FISTULA SITE COMPLICATION 238 0.3967
8 ANTICOAGULANT THERAPY 90 0.3169
9 HEART FAILURE WITH PRESERVED EJECTION FRACTION 81 0.2755
See all enriched reactions for Erythropoiesis-stimulating Agent [EPC]